Last reviewed · How we verify

NCT07585292

Transcutaneous Auricular Vagus Nerve Stimulation as a Treatment for Musculoskeletal Pain in Cerebral Palsy

Not yet recruiting NA
What this trial tests

NA trial testing Active Transcutaneous Auricular Vagus Nerve Stimulation in Cerebral Palsy (CP) in 32 participants. Not yet recruiting.

Timeline
1 October 2026
31 May 2029

Quick facts

Lead sponsorLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
PhaseNA
StatusNot yet recruiting
Enrollment32
Start date1 October 2026
Estimated completion31 May 2029

Drugs / interventions tested

Conditions studied

Sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Who can join

Eligibility, any sex, with Cerebral Palsy (CP) or Musculoskeletal Pain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Active Transcutaneous Auricular Vagus Nerve Stimulation

Trials testing the same drug.

Other recruiting trials for Cerebral Palsy (CP)

Currently open trials in the same condition.

Other London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07585292.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing